Peer Exchange

The Pharmacy Times® Peer Exchange series is built around video panel discussions featuring some of the most recognizable names in pharmaceuticals. Each program focuses on a specific disease, condition, or therapy, and boasts energetic, moderated conversation on a variety of subjects and questions pertaining to the topic at hand.

What can we help you find?
ITP
Frontline options commonly used to treat immune thrombocytopenia and variables that affect treatment selection.
ITP
Strategies and types of tests used by clinicians to help exclude various conditions that may present similarly to immune thrombocytopenia during a diagnostic work-up.
ITP
A discussion on the risks of bleeding episodes and venous thromboembolism associated with immune thrombocytopenia.
Immune Thrombocytopenia
A description of what immune thrombocytopenia is and presenting factors that prompt providers to refer patients to be assessed by a specialist for the condition.
biosimilars
Considerations of biosimilars as a valuable asset to the health care system, the impact of the competition biosimilars have on biologics regarding price and rebates, and final thoughts.
biosimilars
A discussion on the pricing of biosimilars and factors that limit the cost-savings potential.
biosimilars
Common myths and misconceptions for biosimilars are explored.
Bio
The panel discusses patient awareness of biosimilar products and whether they provide supplemental patient education through patient information sheets.
biosimilars
Raising clinician awareness of using biosimilar products.
biosimiliar
The scope of the clinical pharmacist is discussed in switching a patient over to a preferred biosimilar along with the role of specialty pharmacy.
biosimilars
A discussion on limiting the number of biosimilars available for the same product at an institution regarding inventory, fridge space, and safety.
biosimilars
The panel explores the appropriateness of switching from a biologic to a biosimilar through consideration of factors such as the curative vs noncurative setting, the EMR system, and patient education.